December 10, 2020 by Chain Drug Review
Figures and Trends, HDA Research Foundation, Specialty Pharmaceutical Distribution: Facts
Leading Headlines, Pharmacy
ARLINGTON, Va. — New data released today by the HDA Research Foundation illustrate the continued supply chain efficiencies generated by HDA-member specialty distributors. According to the latest edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends, specialty distributors are a vital nexus between 176 manufacturers and more than 49,000 provider ship-to points for administration or dispensing to patients.
December 3, 2020 by Chain Drug Review
2019 HDA Factbook, HDA Research Foundation, Perry Fri
Leading Headlines, Pharmacy
ARLINGTON, Va. — Data published today by the HDA Research Foundation reveal an estimated 93% of all U.S. pharmaceutical sales were completed through HDA-member traditional pharmaceutical distributors in 2019. As illustrated in the 91st Edition HDA Factbook, total distributor sales reached $519 billion. “Each year, the Factbook quantifies the role distributors play as the critical connection
December 13, 2019 by Chain Drug Review
Figures and Trends, HDA Research Foundation, Perry Fri, The 2019 Specialty Pharmaceutical Distribution: Facts
Leading Headlines, Pharmacy
ARLINGTON, Va. — A new analysis published by the HDA Research Foundation indicates that oncology drugs, autoimmune and HIV therapeutics fueled specialty pharmaceutical segment growth in 2018. The 2019 Specialty Pharmaceutical Distribution: Facts, Figures and Trends indicates that oncology therapeutics account for most specialty distributor sales at 48.4%. “Specialty drugs account for nearly half of
December 6, 2019 by Chain Drug Review
Figures and Trends in Healthcare (2019–2020), HDA Research Foundation, Perry Fri, The 90th Edition HDA Factbook: The Facts
Leading Headlines, Pharmacy
ARLINGTON, Va. — In 2018, sales through pharmaceutical distributors increased by 6.7%, reaching $492.54 billion, according to a new report by the HDA Research Foundation. The 90th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2019–2020) also notes that chain drug stores were the largest customer base for pharmaceutical wholesalers — accounting for
July 15, 2019 by Chain Drug Review
“The Risks and Realities of Commercial Drug Importation”, HDA Research Foundation, Perry Fri
Leading Headlines, Pharmacy
ARLINGTON, Va. — A new report published by the HDA Research Foundation concludes that federal proposals to permit the importation of prescription drugs into the U.S. fail to provide comprehensive guidance and funding to meet current federal safety and quality standards. As highlighted in the report, “The Risks and Realities of Commercial Drug Importation,” implementation
February 14, 2019 by Chain Drug Review
HDA Research Foundation, Perry Fri
Leading Headlines
ARLINGTON, Va. — The HDA Research Foundation Thursday announced the selection of four HDA-member professionals as the inaugural recipients of its graduate-level scholarship program. The scholarship, developed as part of the organization’s mission to foster industry knowledge and established in conjunction with HDA’s Convene program, is available annually to graduate-level students working within HDA-member distributor and manufacturer companies.
December 18, 2018 by Chain Drug Review
2018 Specialty Pharmaceutical Distribution: Facts, Figures and Trends publication, HDA Research Foundation, Perry Fri
Leading Headlines, Pharmacy
ARLINGTON, Va. — Data published by the HDA Research Foundation reveal the changing market dynamics of the nearly $200 billion specialty pharmaceutical supply chain segment — and the important role HDA-member specialty pharmaceutical distributors play within it. The 2018 Specialty Pharmaceutical Distribution: Facts, Figures and Trends publication is based on an annual survey of HDA-member
December 11, 2018 by Chain Drug Review
89th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2018–2019), HDA Research Foundation
Leading Headlines, Pharmacy
ARLINGTON, Va. — The HDA Research Foundation released the 89th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2018–2019), featuring updated data trends on the pharmaceutical distribution industry. According to the latest findings, chain drug stores remained the largest customer segment for distributors in 2017, representing 42.6%t of all sales — a 10.2% increase from the
August 6, 2018 by Chain Drug Review
and Bradford Rx Solutions, Drug Supply Chain Security Act, HDA Research Foundation, Kindler & Crimmins Associates, LLC, The Role of Reverse Distribution
Business, Leading Headlines, Pharmacy, Supplier News
ARLINGTON, Va.— A new report published by the HDA Research Foundation entitled The Role of Reverse Distribution provides insights into the reverse distribution of pharmaceutical products. The Foundation estimates that this channel accounts for 3.5 to 4% of all pharmaceutical sales — more than 120 million product units — and exceeds $13 billion in product value. Reverse distribution
June 12, 2018 by Chain Drug Review
HDA Research Foundation, Healthcare Distribution Alliance, John Gray, Michael Conley, Novartis Pharmaceuticals Corp., Perry Fri
Leading Headlines, Pharmacy
COLORADO SPRINGS, Colo. — The HDA Research Foundation, the non-profit organization of the Healthcare Distribution Alliance (HDA), recognized Michael Conley of Novartis Pharmaceuticals Corp. with the 2018 Nexus Award for Lifetime Achievement at the HDA Business and Leadership Conference in Colorado Springs. The award is made possible through the support of Genentech, A Member of the
December 13, 2017 by Chain Drug Review
HDA Research Foundation, Specialty Pharmaceutical Distribution
Pharmacy, Supplier News
ARLINGTON, Va. — In the specialty pharmaceutical arena, products in the autoimmune/immune and ophthalmology categories stand to grow in importance over the next 12 months, followed by oncology, central nervous system and inflammatory drugs, according to the HDA Research Foundation. Oncology still represents for the biggest share of specialty drug distributor sales volume, based on
December 5, 2017 by Chain Drug Review
2017 HDA Factbook, Drug Supply Chain Security Act, DSCSA, HDA Factbook, HDA Research Foundation, Healthcare Distribution Alliance, Perry Fri, U.S. pharmaceutical distributors
Leading Headlines, Pharmacy, Supplier News
ARLINGTON, Va. — Chain drug stores remain the largest customer segment for U.S. pharmaceutical distributors, according to the HDA Research Foundation. The 88th Edition HDA Factbook (2017‐2018) said chain drug retailers accounted for nearly 30% of all sales to drug distributors last year. Dollar sales to independent pharmacies dipped 1.1%, while sales to hospitals and
June 14, 2017 by Chain Drug Review
2017 DIANA award, 2017 Nexus Award for Lifetime Achievement, Distribution Industry Awards for Notable Achievements in Healthcare, Endo, HDA 2017 Business and Leadership Conference, HDA Research Foundation, Healthcare Distribution Alliance, John Gray, Michael McBride, Par Pharmaceutical, Paul Campanelli, Power of Partnership Award, Rusty Field, Upsher-Smith Laboratories
Leading Headlines, Pharmacy, Supplier News
PHOENIX — The Healthcare Distribution Alliance (HDA) this week presented its annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA) to pharmaceutical manufacturers for supply chain innovation and collaboration. Given at the HDA 2017 Business and Leadership Conference in Phoenix, the DIANA awards honor HDA member manufacturers that develop innovative new products and promotions
February 23, 2017 by Chain Drug Review
Apotex, Cardinal Health, Craig Cowman, Genentech, Greg Drew, HDA, HDA Executive Committee, HDA Research Foundation, Healthcare Distribution Alliance, James Reilly, Jeffrey Hampton, John Gray, Morris & Dickson, Paul Dickson, Value Drug
Supplier News
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) has made new appointments to its executive committee and HDA Research Foundation board of directors. HDA said Thursday that Paul Dickson, president of Morris & Dickson Co., has been elected as a member of the HDA Executive Committee. He currently serves as a member of the HDA
